Split Creek Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Split Creek Capital's VRTX Position: Q3 2026 in Review
Split Creek Capital increased its Vertex Pharmaceuticals (VRTX) stake by 10% in Q3 2026, buying an estimated $28.2K and bringing the position to 590 shares worth $308K. The position accounts for 0.29% of the portfolio, ranked #105.
Split Creek Capital first reported a position in VRTX in Q2 2026 and has held it in 2 quarters since. 1,556 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- Split Creek Capital held 590 shares of Vertex Pharmaceuticals worth $308K as of Q3 2026.
- Split Creek Capital bought 55 Vertex Pharmaceuticals shares in Q3 2026, an estimated $28.2K.
- Vertex Pharmaceuticals made up 0.29% of Split Creek Capital's portfolio in Q3 2026, its #105 holding.
- Split Creek Capital first reported a position in Vertex Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
- 1,556 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on Split Creek Capital's 13F filing for Q3 2026, filed 2 Nov 2026.